Evaluating Patients with Cirrhosis for Hepatocellular Carcinoma: Value of Clinical Symptomatology, Imaging and Alpha-Fetoprotein

Publisher： Karger

E-ISSN： 1423-0232|72|1|117-123

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.1, 2007-12, pp. : 117-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low alpha‐fetoprotein hepatocellular carcinoma

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 9, 2010-09 ,pp. : 1543-1549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2150-2157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 9, 2015-09 ,pp. : 1405-1411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiplication of alpha‐fetoprotein and protein induced by vitamin K absence‐II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E21-E31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1250-1258

John Wiley & Sons Inc

Access to resources Recommend Favorite